Validation of trans-acting elements that promote exon 7 skipping of SMN2 in SMN2-GFP stable cell line

Biochemical and Biophysical Research Communications

Volumn 423, Issue 3, 2012, Pages 531-535

  Cho, Sunghee ^a   Moon, Heegyum ^a   Yang, Xiaoming ^b   Zhou, Jianhua ^b   Kim, Hye Ran ^c,d   Shin, Myung Geun ^c   Loh, Tiing Jen ^a   Zheng, Xuexiu ^a   Shen, Haihong ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b NANTONG UNIVERSITY   (China)

^c Chonnam National University Medical School   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

SMN1; SMN2; Spinal muscular atrophy; Splicing; Stable cell line; Trans acting elements

Indexed keywords

GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER RNA PRECURSOR; SHORT HAIRPIN RNA; SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL LINE; CONTROLLED STUDY; EXON; EXON 7; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOBLOTTING; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL MUSCULAR ATROPHY;

ALTERNATIVE SPLICING; CELL LINE; EXONS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; MUSCULAR ATROPHY, SPINAL; PROTEIN BIOSYNTHESIS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA PRECURSORS; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 84863327340     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.161     Document Type: Article

References (40)

1. Classification of spinal muscular atrophies. Med. J. Aust. 1980, 2(3):116.
2. Li Q., Lee J.A., Black D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 2007, 8(11):819-831.
3. Bergin A., Kim G., Price D.L., et al. Identification and characterization of a mouse homologue of the spinal muscular atrophy-determining gene, survival motor neuron. Gene 1997, 204(1-2):47-53.
4. Cobben J.M., de Visser M., Scheffer H. From gene to disease; 'survival' motor neuron protein and hereditary proximal spinal muscle atrophy. Ned. Tijdschr Geneeskd 2001, 145(52):2525-2527.
5. Lefebvre S., Burglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80(1):155-165.
6. Carvalho T., Almeida F., Calapez A., et al. The spinal muscular atrophy disease gene product, SMN: a link between snRNP biogenesis and the Cajal (coiled) body. J. Cell. Biol. 1999, 147(4):715-728.
7. McAndrew P.E., Parsons D.W., Simard L.R., et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum. Genet. 1997, 60(6):1411-1422.
8. Monani U.R., Lorson C.L., Parsons D.W., et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 1999, 8(7):1177-1783.
9. Lorson C.L., Hahnen E., Androphy E.J., et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(11):6307-6311.
10. Cartegni L., Hastings M.L., Calarco J.A., et al. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am. J. Hum. Genet. 2006, 78(1):63-77.
11. Gennarelli M., Lucarelli M., Capon F., et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem. Biophys. Res. Commun. 1995, 213(1):342-348.
12. Kashima T., Manley J.L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 2003, 34(4):460-463.
13. Sinrin A.S. RNA world and its evolution. Mol. Biol. (Mosk) 2005, 39(4):550-556.
14. Saltzman A.L., Pan Q., Blencowe B.J. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 2011, 25(4):373-384.
15. Maniatis T., Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 2002, 418(6894):236-243.
16. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
17. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 2002, 30(1):13-19.
18. Lopez A.J. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 1998, 32:279-305.
19. Smith C.W., Valcarcel J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 2000, 25(8):381-388.
20. Anko M.L., Muller-McNicoll M., Brandl H., et al. The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. Genome Biol. 2012, 13(3):R17.
21. Bourgeois C.F., Lejeune F., Stevenin J. Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. Prog. Nucleic Acid Res. Mol. Biol. 2004, 78:37-88.
22. Jurica M.S., Moore M.J. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell. 2003, 12(1):5-14.
23. Graveley B.R. Sorting out the complexity of SR protein functions. RNA 2000, 6(9):1197-1211.
24. Busch A., Hertel K.J. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA 2012, 3(1):1-12.
25. Abrams J., Davuluri G., Seiler C., et al. Smooth muscle caldesmon modulates peristalsis in the wild type and non-innervated zebrafish intestine. Neurogastroenterol. Motil. 2012, 24(3):288-299.
26. Chaudhury A., Chander P., Howe P.H. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 2010, 16(8):1449-1462.
27. Mayeda A., Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992, 68(2):365-375.
28. Sheng Z., Li L., Zhu L.J., et al. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat. Med. 2010, 16(6):671-677.
29. Hart D.O., Raha T., Lawson N.D., et al. Initiation of zebrafish haematopoiesis by the TATA-box-binding protein-related factor Trf3. Nature 2007, 450(7172):1082-1085.
30. Gazin C., Wajapeyee N., Gobeil S., et al. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007, 449(7165):1073-1077.
31. Berns K., Hijmans E.M., Mullenders J., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004, 428(6981):431-437.
32. McIntyre G.J., Fanning G.C. Design and cloning strategies for constructing shRNA expression vectors. BMC Biotechnol. 2006, 6:1.
33. Paddison P.J., Caudy A.A., Bernstein E., et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 2002, 16(8):948-958.
34. Azzouz M., Le T., Ralph G.S., et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest. 2004, 114(12):1726-1731.
35. Kashima T., Rao N., David C.J., et al. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. Hum. Mol. Genet. 2007, 16(24):3149-3159.
36. Zhang M.L., Lorson C.L., Androphy E.J., et al. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther. 2001, 8(20):1532-1538.
37. Givan A.L. Flow cytometry: an introduction. Methods Mol. Biol. 2004, 263:1-32.
38. Ibrahim S.F., van den Engh G. Flow cytometry and cell sorting. Adv. Biochem. Eng. Biotechnol. 2007, 106:19-39.
39. Villas B.H. Flow cytometry: an overview. Cell Vis. 1998, 5(1):56-61.
40. Bundey S., Lovelace R.E. A clinical and genetic study of chronic proximal spinal muscular atrophy. Brain 1975, 98(3):455-472.